Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Desogestrel Versus GnRH Antagonist (Ganirelix) in IVF/ICSI Patients Undergoing Ovarian Stimulation: a Randomized Controlled Trial

NCT04728659 is registered in ClinicalTrials.gov with Casa di Cura Privata Villa Mafalda as lead sponsor.

NCT NCT04728659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04728659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Desogestrel Versus GnRH Antagonist (Ganirelix) in IVF/ICSI Patients Undergoing Ovarian Stimulation: a Randomized Controlled Trial
Lead sponsor
Casa di Cura Privata Villa Mafalda
Phase
Phase 4
Overall status
Unknown status
Start date
October 1, 2020
Completion date
February 28, 2022
Enrollment
165 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, ivf